Addex Therapeutics Ltd Asset Resilience Ratio

Latest as of March 2026: 0.05%

Addex Therapeutics Ltd asset resilience ratio. Addex Therapeutics Ltd (ADXN) has an Asset Resilience Ratio of 0.05% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Addex Therapeutics Ltd (ADXN) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CHF2.35K

≈ $2.97K USD Cash + Short-term Investments

Total Assets

CHF4.76 Million

≈ $6.02 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Addex Therapeutics Ltd (2017–2025)

Asset resilience ratio of Addex Therapeutics Ltd from 2017 to 2025. This chart shows how Addex Therapeutics Ltd's Asset Resilience Ratio has changed over time. Read ADXN total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Addex Therapeutics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see ADXN total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CHF0.00	0%
Short-term Investments	CHF2.35K	0.05%
Total Liquid Assets	CHF2.35K	0.05%

Asset Resilience Insights

Limited Liquidity: Addex Therapeutics Ltd maintains only 0.05% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Addex Therapeutics Ltd Industry Peers by Asset Resilience Ratio

Compare Addex Therapeutics Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Hyloris Developmentsen Sa BR:HYL	Biotechnology	1.36%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Oruka Therapeutics, Inc. NASDAQ:ORKA	Biotechnology	53.11%
Gempharmatech Co. Ltd. A SHG:688046	Biotechnology	23.95%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	74.48%
Inventiva S.A PA:IVA	Biotechnology	52.73%
Sunmax Biotechnology Co Ltd TWO:4728	Biotechnology	10.53%
Guangdong VTR Bio-Tech Co Ltd SHE:300381	Biotechnology	4.98%

Addex Therapeutics Ltd Asset Resilience Ratio by Year (2017–2025)

Addex Therapeutics Ltd asset resilience ratio by year from 2017 to 2025. The table below shows the annual Asset Resilience Ratio data for Addex Therapeutics Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.08%	CHF5.13K ≈ $6.49K	CHF6.36 Million ≈ $8.04 Million	+0.02pp
2024-12-31	0.06%	CHF6.50K ≈ $8.21K	CHF10.67 Million ≈ $13.49 Million	-83.23pp
2023-12-31	83.29%	CHF3.87 Million ≈ $4.89 Million	CHF4.64 Million ≈ $5.87 Million	-0.75pp
2022-12-31	84.04%	CHF6.96 Million ≈ $8.80 Million	CHF8.28 Million ≈ $10.47 Million	-6.91pp
2021-12-31	90.95%	CHF20.50 Million ≈ $25.92 Million	CHF22.54 Million ≈ $28.50 Million	-2.00pp
2020-12-31	92.95%	CHF18.76 Million ≈ $23.72 Million	CHF20.18 Million ≈ $25.52 Million	+78.84pp
2019-12-31	14.11%	CHF4.66 Million ≈ $5.89 Million	CHF33.03 Million ≈ $41.76 Million	+14.09pp
2018-12-31	0.02%	CHF7.98K ≈ $10.09K	CHF42.21 Million ≈ $53.37 Million	-0.35pp
2017-12-31	0.37%	CHF11.29K ≈ $14.27K	CHF3.06 Million ≈ $3.87 Million	--

pp = percentage points

About Addex Therapeutics Ltd

SW:ADXN Switzerland Biotechnology

Market Cap

$4.11 Million

CHF3.25 Million CHF

Market Cap Rank

#29012 Global

#213 in Switzerland

Share Price

CHF0.02

Change (1 day)

-5.31%

52-Week Range

CHF0.02 - CHF0.06

All Time High

CHF3.90